MetaImmuneTech Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $327K

  • Investors
  • 5

MetaImmuneTech General Information

Description

Developer of a digital cell analysis platform designed to enable rapid, label-free analysis of immune cells for diagnostics, immune monitoring, and cell therapy development. The company offers proprietary Lens-free Shadow Imaging Technology and the Cellytics platform for analyzing immune cell count, morphology, and function, enabling researchers and healthcare organizations to assess immune cells without labeling.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2511, 310/509/508 Industry-Academic Cooperation Center
  • Sejong-ro
  • Sejong, Sejong 30019
  • South Korea
+82
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Corporate Office
  • 2511, 310/509/508 Industry-Academic Cooperation Center
  • Sejong-ro
  • Sejong, Sejong 30019
  • South Korea
+82

MetaImmuneTech Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MetaImmuneTech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Seed Round 03-Jul-2026 $327K Completed Generating Revenue
6. Seed Round 04-Dec-2025 Completed Generating Revenue
5. Angel (individual) 20-Jun-2024 Completed Generating Revenue
4. Seed Round 13-Oct-2023 Completed Generating Revenue
3. Accelerator/Incubator 01-Apr-2024 Completed Generating Revenue
2. Seed Round 25-Apr-2022 $81.5K $81.5K Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2022 Completed Generating Revenue
To view MetaImmuneTech’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

MetaImmuneTech Patents

MetaImmuneTech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026177331-A1 Method, device and kit for analyzing immune cells for companion animals Pending 20-Feb-2025
WO-2026054439-A1 Device and method for diagnosing infectious disease using lens-free shadow imaging technology based on t cell response Pending 03-Sep-2024
US-12770257-B2 Apparatus for analyzing natural killer cell activity using lens-free shadow imaging technique, and method therefor Active 17-Sep-2021
US-20250131557-A1 Apparatus for analyzing natural killer cell activity using lens-free shadow imaging technique, and method therefor Active 17-Sep-2021
WO-2023042999-A1 Apparatus for analyzing natural killer cell activity using lens-free shadow imaging technique, and method therefor Inactive 17-Sep-2021 G06T7/0012
To view MetaImmuneTech’s complete patent history, request access »

MetaImmuneTech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MetaImmuneTech Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Boditech Med Corporation Minority
Vaxcell-Bio Therapeutics Corporation Minority
Tech Incubator Program for Startup Accelerator/Incubator
Korea University Holdings Accelerator/Incubator Minority
KU Startup Accelerator/Incubator
To view MetaImmuneTech’s complete investors history, request access »

MetaImmuneTech FAQs

  • When was MetaImmuneTech founded?

    MetaImmuneTech was founded in 2020.

  • Where is MetaImmuneTech headquartered?

    MetaImmuneTech is headquartered in Sejong, South Korea.

  • What is the size of MetaImmuneTech?

    MetaImmuneTech has 6 total employees.

  • What industry is MetaImmuneTech in?

    MetaImmuneTech’s primary industry is Diagnostic Equipment.

  • Is MetaImmuneTech a private or public company?

    MetaImmuneTech is a Private company.

  • What is the current valuation of MetaImmuneTech?

    The current valuation of MetaImmuneTech is .

  • What is MetaImmuneTech’s current revenue?

    The current revenue for MetaImmuneTech is .

  • How much funding has MetaImmuneTech raised over time?

    MetaImmuneTech has raised $1.21M.

  • Who are MetaImmuneTech’s investors?

    Boditech Med, Vaxcell-Bio Therapeutics, Tech Incubator Program for Startup, Korea University Holdings, and KU Startup have invested in MetaImmuneTech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process